YourVoice.Now
Back to Dashboard
HR-920Crime and Law Enforcement

Federal Initiative to Guarantee Health by Targeting Fentanyl Act

YourVoice.Now SummaryCriminal Justice & Due Process

Fentanyl analogs — lab-made variations of fentanyl that are chemically tweaked just enough to skirt existing drug laws — would be permanently classified as Schedule I controlled substances under this bill. That means any substance structurally related to fentanyl, including new variants that haven't been individually banned yet, would automatically be illegal to manufacture, distribute, or possess. However, the bill specifically removes mandatory minimum prison sentences for these substances, giving judges more flexibility in sentencing while still closing the legal loophole that drug makers have exploited.

Criminal Justice & Due Process

  • Schedule I scope for fentanyl-related substances — Permanent class-wide listing covers any compound matching one of five structural modifications
  • Reach of federal drug-trafficking penalties — Extends to compounds not individually assessed, including some research-relevant analogs

Congressional Summary

Federal Initiative to Guarantee Health by Targeting Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill prohibits the application of a mandatory minimum prison term for certain drug offenses involving fentanyl-related substances.

Details

Congress
119th
Chamber
Status
summarized
Action
Action Date
Date Added
2026-04-02
Source
Congress.gov →

Like reading a bill in plain English?

We're building an app that does this for every bill in Congress and lets you tell your reps how you want them to vote. We're a small team getting ready to launch, and we're trying to show investors that real people want this. Be one of them. Help us get it built. Leave your email and we'll tell you the moment the app is ready.

By default, we'll only email you once — when the app launches. Unless you opt in below, you won't receive anything else. We don't share or sell your email.